ARCHIVES

Cuts Claimed to Displace “Millions” of Patients Yet None Seem to Complain. Why Not?

This article is from The Cancer Letter archive.

Vol. 39 No. 17 | April 25, 2013

Download PDF Visit The Full Archive

Related Articles

Weekly Paclitaxel Better Than Every Three Weeks

June 25, 2004

In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs

January 17, 1992

PDQ Now Offers CME Credit to Physician Users

July 3, 1987

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

Two-Month Survival Benefit For Some NSCLC Patients

May 31, 2002

NCI Advisors Ok Study of Cancer In Farmers; Commit $6.6 Million to Five Year Contracts

April 3, 1992